DEADLINE(S)SPONSOROPPORTUNITY TITLE/LINKADDITIONAL INFORMATION

September 15, 2020

NEW (08/10/20)

Office of the Director, National Institutes of Health

Participating NIH Components:

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism

National Institute of Child Health and Human Development

National Center for Complementary and Integrative Health

National Cancer Institute

National Heart, Lung and Blood Institute

Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial not Allowed) (RFA-OD-20-014)This Request for Applications will support early stage development of an innovative platform that integrates biosensing with touchscreen or other digital devices to achieve detection and tracing of SARS-CoV-2 in real-time. It is part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.

September 15, 2020

NEW (08/10/20)

Office of the Director, National Institutes of Health

Other Participating Components:

National Institute on Aging

National Institute of Child Health and Human Development

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute of Neurological Disorders and Stroke

National Library of Medicine

Office of Research on Women's Health

Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Not Allowed) (RFA-OD-20-022)NIH is soliciting applications to enhance the utility of chemosensory testing as a COVID-19 screening tool.

September 18, 2020

NEW (08/10/20)

Office of the Director, National Institutes of Health (and other participating institutes)Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) (RFA-OD-20-018)

Through this opportunity, NIH is seeking to use developed technologies for single vesicle or exosome isolation and analysis and reposition these technologies for detection of COVID-19.

Note institutions are limited to one application for this RFA; our internal selection process runs through the Office of the Vice Chancellor for Research.

September 30, 2020

NEW (08/10/20)

Office of the Director, National Institutes of Health (and other participating institutes)Emergency Awards: RADx-rad Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed) (RFA-OD-20-019)

NIH will fund one DCC to serve as a communication center and data hub for Rapid Acceleration of Diagnostics-Radical (RADx-rad) awardees.

Note institutions are limited to one application for this RFA; our internal selection process runs through the Office of the Vice Chancellor for Research.

September 30, 2020

NEW (08/10/20)

Office of the Director, National Institutes of Health

Participating NIH Components:

National Institute on Alcohol Abuse and Alcoholism

National Institute on Deafness and Other Communication Disorders

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Drug Abuse

National Institute of General Medical Sciences

National Institute of Nursing Research

National Institute on Minority Health and Health Disparities

National Library of Medicine

Office of Behavioral and Social Sciences Research

Emergency Awards: RADx-RAD Multimodal COVID-19 Surveillance Methods for High-Risk Clustered Populations (R01 Clinical Trial Optional) (RFA-OD-20-016)Applicants will pursue development and validation studies of COVID-19 surveillance methods not focused on direct viral testing of individuals in settings and institutions with a high density of individuals ho are together for  prolonged periods of time.

September 30, 2020

NEW (08/10/20)

Office of the Director, National Institutes of Health

Other Participating Components:

Fogarty International Center

National Heart, Lung and Blood Institute

National Institute of Allergy and Infectious Diseases

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of Child Health and Human Development

National Institute on Drug Abuse

National Institute on Minority Health and Health Disparities

Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kids) (R61/R33 Clinical Trial Optional) (RFA-OD-20-023)NIH will support innovative research to develop novel, new or unique and non-traditional approaches to identify and characterize the spectrum of SARS-CoV-2 associated illness, including the multisystem inflammatory syndrome in children (MIS-C), and through a prognostic algorithm, predict the longitudinal risk of disease severity after a child is exposed to and may be infected with SARS-CoV-2 to properly tailor his or her management and optimize health outcomes.

September 18, 2020

NEW (08/10/20)

Office of the Director, National Institutes of Health (and other participating institutes)Emergency Awards: RAD-x RAD Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) (RFA-OD-20-017)

NIH is seeking applications for a portable sensing device to detect volatile organic compounds emanating from skin or exhaled breath, saliva and different oral tissues from the oral cavity. 

Note institutions are limited to one application for this RFA; our internal selection process runs through the Office of the Vice Chancellor for Research.

September 15, 2020

NEW (08/10/20)

Office of the Director, National Institutes of Health

Participating NIH Components:

National Institute on Drug Abuse

National Institute of Environmental Health Sciences

National Institute of General Medical Sciences

National Library of Medicine

Emergency Awards: RAD-x Wastewater Detection of SARS-CoV-2 (COVID-19) (U01 Clinical Trials Not Allowed) (RFA-OD-20-015)NIH will support wastewater-based testing surveillance to provide detailed mapping of the extent and spread of COVID-19. This RFA is part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.

August 21, 2020

NEW (08/10/20)

Office of the Director, National Institutes of Health

Participating Institute:

National Library of Medicine (NLM)

Notice of Special interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19) (NOT-OD-20-159)This opportunity is limited to current NLM R01 awardees, and will focus on informatics and data science methods to help address wastewater surveillance to identify "hot spot" geographic areas for public response.

September 15, 2020

NEW (08/10/20)

Office of the Director, National Institutes of Health

Participating NIH Components:

National Institute on Aging

National Institute of Child Health and Human Development

National institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute of Nursing

Office of Research on Women's Health

Notice of Special Interest (NOSI): Availability of Emergency Revisions for Chemosensory Testing as a COVID-19 Screening Tool (NOT-OD-20-152)This program provides an expedited funding mechanism for proposals to enhance the utility of chemosensory testing as a COVID-19 screening tool by using objective tests to examine the onset and prognostic value of chemosensory loss and to encourage development and/or deployment of home-based and on-site chemosensory tests. Eligible parent awards on which the revision application is based must be active awards managed by one of the participating institutes.

Applications accepted on rolling basis; scientific review occurs in June and December

23andMeResearch Innovation Collaborations ProgramAs related to COVID-19, 23andMe will consider studies of outcomes, co-morbidities, health disparities and impacts of policies implemented to address the pandemic. Academic researchers are paired with 23andMe scientists and gain access to de-identified data from the 23andMe Research Cohort.

August 14, 2020 for optional letters of intent

September 3, 2020 for full applications

Administration on Aging (AoA)Lifespan Respite Care Program: Special Projects to Strengthen Program Development, Implementation and Sustainability (HHS-2020-ACL-AOA-LRSP-0432)Lifespan Respite Care programs are coordinated systems of accessible, community-based respite care services for family caregivers of children or adults with special needs. Special projects funded may: 1) Develop, test and scale a respite workforce recruitment, training and retention program to better meet respite needs of families, particularly in light of the impact of the COVID-19 pandemic on the workforce; 2) Develop and field test a state-based framework and road map for respite system planning and development; and 3) Strengthen and test enhanced approaches to help caregivers and families develop or strengthen their own natural support systems.
The sponsor indicates the initial submission deadline is June 30, 2020 but there may be additional opportunities in the future.Amazon Web Services (AWS)AWS Diagnostic Development InitiativeThis Initiative supports AWS customers who are working to bring better, more accurate diagnostic solutions to market faster. Focused initially on COVID-19, researchers studying other infectious diseases will also be supported.
Continuous submissionArgonne National Laboratory (US Department of Energy)Expedited, Rapid Access Call for COVID-19 Research SupportThe Advanced Photon Source at Argonne is offering remote access to beamlines for macromolecular crystallography and BioSAXS for research efforts related to SARS-CoV-2 or COVID-19.
No deadline indicatedArmy Applications Laboratory (AAL)COVID-19 InnovationsAAL is seeking information on innovative medical equipment, therapeutics, diagnostics and vaccines relative to COVID-19. The first step is to schedule a telephone call with the agency to discuss your innovative idea(s).

March 17, 2021

Basic Behavioral and Social Science Opportunity Network (NIH OPPNET)Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Well-Being, Illness and Recovery (R01)This Notice adds a deadline date and interests specific to COVID-19.
No deadline specifiedBoehringer IngelheimInvestigator-Initiated Studies (IIS): Established ProductsThe sponsor's purpose is to evaluate potential clinical and non-clinical investigations involving COVID-19 related matters including safety, clinical outcomes, antiviral effects or antithrombotic benefits.
One-page Expressions of Interest are due July 15, 2020; invited full applications will then be due August 31, 2020.British Society for Antimicrobial Chemotherapy (BSAC)BSAC COVID-19 Funding CallBSAC has issued a worldwide call for applications and is most interested in receiving applications 1) from researchers in low-to-middle-income countries (LMICs) or applications that address aspects of COVID-19 in LMIC communities; or 2) that address the impact of COVID-19 on the antimicrobial resistance and antimicrobial stewardship agenda.
Continuous submissionBrookhaven National Laboratory (US Department of Energy)COVID-19 Research SupportThe Center for Biomolecular Structure is supporting remote macromolecular crystallography experiments at the AMX and FMX beamlines and solution scattering experiments at the LiX beamline for COVID-19 research.
September 11, 2020Center for Sharing Public Health ServicesCall for Proposals: Increasing the Body of Knowledge for Cross-Jurisdictional Sharing in Public Health - Small Grants ProgramThe Center will support work on cross-jurisdictional sharing (CJS) arrangements designed to advance health equity by addressing social determinants of health (e.g., affordable housing, jobs with fair pay, quality education, affordable healthy food, public safety), the public health response to COVID-19, structural racism or other related issues. This program will fund projects involving a specific CJS arrangement or efforts to use CJS as a systems change tool. (Note universities are eligible for this opportunity.)
August 7, 2020CHEST FoundationCHEST Foundation Research Grant in COVID-19Applications must address clinical (in-hospital or outpatient) or community-related aspects of COVID-19. Eligible applicants are CHEST members; licensed physicians, residents, fellows, other clinical care professionals and clinical researchers with relevant experience may apply.
Proposals accepted anytime, but plan to submit as soon as possible; the sponsor notes that the RFP will be closed as specific topics are addressedCisco Systems, Inc.Pandemic/COVID-19 Science, Technology and Social Impact (RFP-20-04)With the overall focus on being better prepared for pandemics, Cisco is sponsoring research that will provide tools for the COVID-19 emergency and those in the future. Areas of interest include predictive analytics, sensor devices and advanced computational biology. Cisco is hoping to cultivate stronger relationships with scientists and technologists to accelerate needed scientific research.
Applications accepted on a rolling basis at least through September 28, 2020Coalition for Epidemic Preparedness Innovations (CEPI)COVID-19 Vaccines: Accelerating Vaccine Development and Global Manufacturing Capacity to Stop the PandemicThis call for proposals is designed to accelerate the development of safe and effective vaccines by organizations worldwide who can rapidly deliver at scale to insure the supply of vaccine doses will meet public health need on a worldwide basis during the pandemic.
Applications accepted on rolling basisCOVID-19 Early Treatment Fund (CETF)Grants ProgramAdvocating early, effective treatment for COVID-19 patients designed to prevent hospitalization, CETF is supporting outpatient clinical trials of re-purposed antiviral drugs. 
July 17, 2020 for required letters of intent; full applications due October 1, 2020Cystic Fibrosis Foundation (CFF)SARS-CoV-2 and Cystic FibrosisThe sponsor will fund basic research projects that will improve understanding of SARS-CoV-2 pathogenesis in cystic fibrosis. Eligible applicants are independent investigators, and can be current or past CFF awardees.
Continuous submissionDepartment of Energy
(US DOE)
Dear Colleague Letter - Corona Virus Disease 2019 (COVID-19)DOE is encouraging submission of scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure.
Continuous submissionDepartment of Energy (DOE)Rapid Access for COVID-19 ResearchDOE is offering remote access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapeutics.
October 31, 2020
(this is final white paper submission deadline; full proposals will be invited by the sponsor)
Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)Broad Agency Announcement (BAA)BARDA has updated this BAA to reflect its current Areas of Interest (AOI), all related to COVID-19: 
AOI 7.7.1 Diagnostic assay for human coronavirus using existing FDA-cleared platforms; 

AOI 7.7.2 Point-of-care diagnostic assay for  detection of SARS-CoV-2 virus; 
AOI 7.7.3 Diagnostic assay for detection of COVID-19 disease (SARS-CoV-2 infection), Including Serology Tests
AOI 7.7.4 Diagnostic Assay for SARS-CoV-2 as part of FDA-cleared panel for influenza and other respiratory viruses using FDA-cleared platforms
AOI 8.3 COVID-19 Vaccine
AOI 9.2 COVID-19 Therapeutics
AOI 17 Advanced Manufacturing Technologies

October 31, 2020
(open for abstract submission through this date)
Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)

Division of Research Innovations and Ventures Easy Broad Agency Announcement (DRIVe)

See DRIVe EZ BAA Special instructions 010 for details.

 

While originally published with multiple topics, all have been closed and current work is now devoted to COVID-19. Open Areas of Interest (AOI) are: Remote Patient Monitoring/Remote Diagnostic Tools (AOI #4.1.D); Pediatric Diagnostic Tools for Severe COVID-19 Disease and MIS-C (AOI # 4.1.E); and Alternate Routes of Administration for Vaccines (AOI # 4.3). 

Continuous SubmissionDiamond Light SourceRapid Access Call for Proposals: SARS-CoV-2Diamond, the UK's national synchotron, is offering its facilities and fragment screening expertise to researchers world-wide who are working on COVID-19 related projects.
August 21, 2020Emergency Medicine FoundationFUJIFILM SonoSite COVID-19 Point of Care Ultrasound Acceleration Research GrantThe sponsor's goal is to learn more about and evaluate the role of point of care ultrasound in COVID-19 including mild to severe illness, initial triage, examination and ongoing monitoring and multi-organ assessment.
Applications accepted on rolling basisEmergent VenturesFast Grants for COVID-19The sponsor provides funding for researchers at academic institutions who are currently working on scientific or biomedical COVID-19 projects that could help with the pandemic within the next 6 months. Funding decisions are promised within 14 days for this second round of funding. This grant program is administered by the Mercatus Center at George Mason University.
August 31, 2020Encephalitis SocietyEncephalitis and COVID-19 - International Research Seed FundingOpen to researchers worldwide, this opportunity will support development of innovative ideas concerning encephalitis and COVID-19 to include diagnosis, treatment, recovery and rehabilitation. The sponsor is most interested in funding pilot and proof-of-concept projects. Priority will be given to early career researchers.
Continuous submissionExtreme Science and Engineering Discovery Environment (XSEDE)
(funded by the National Science Foundation)
COVID-19 HPC Consortium

This Consortium houses some of the most powerful and advanced computers in the world which will be made available to researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections.

No deadlineFacebookCrowdTangle Public Application for AcademicsUsing Facebook's CrowdTangle, designed to enhance abilities to follow, analyze and report on what's happening across social media, this opportunity will allow researchers to gain access to CrowdTangle tools/technical support. Projects should be focused on misinformation, elections, COVID-19, racial justice and/or well-being. Applications are for access to CrowdSource; no funding is associated with this opportunity.
None indicatedFacebookSymptom SurveysFacebook is offering access to survey data collected on a national and global level concerning Facebook users and COVID-19 symptoms. The Symptom Survey datasets are managed by Carnegie Mellon University and the University of Maryland. Academic and non-profit researchers may request access to the aggregated survey data. See the website for more details on survey methodology and the process for requesting data access.
Continuous submission until program funds are expended or the COVID-19 pandemic has endedFederal Communications Commission (FCC)COVID-19 Telehealth ProgramAvailable funding of $200 million for this program comes from the recently enacted CARES Act. It's designed to pay eligible health care providers (to include postsecondary educational institutions offering health care instruction, teaching hospitals and medical schools) to provide connected care services for patients by funding telecommunications services, information services and necessary devices. This is not a grant program; instead, after initial approval, provider expenses related to COVID-19 telehealth services for patients will be reimbursed (starting with expenses incurred after March 13, 2020).
Continuous application receipt through October 31, 2020Ferring PharmaceuticalsFerring COVID-19 Investigational Grants in Reproductive Medicine and Maternal HealthFerring will fund exploratory, basic and clinical research efforts about the effects of SARS-CoV-2 on reproduction, pregnancy and fetal/neonatal health. 
Submissions will be uploaded on the FIND website on a rolling basisFoundation for Innovative New Diagnostics (FIND)Open Call for Data - COVID-19

This Switzerland-based non-profit is asking laboratories around the world with any performance data on commercially available in vitro diagnostic tests that detect nucleic acid, viral antigen or antibodies to contribute to a centralized collection of data as a global public good. The data compilation will be made available on the FIND website to enable fast data sharing throughout the diagnostic community. 

Applications accepted on a continuous basisFoundation for Opioid Response Efforts (FORE)Strengthening Access to Care for Opioid Use Disorder Patients During the COVID-19 National Public Health Emergency: Recovery Support ServicesFORE will fund projects designed to provide evidence-based opioid use disorder recovery support services in the context of social distancing and infection control including promotion of remote, digital and virtual forms of recovery support to reach vulnerable and high-risk populations. Populations of interest include rural communities, urban and minority communities, children and adolescents, pregnant and parenting women, veterans, justice-involved individuals, homeless individuals, the LGBT community, and Native Americans and tribal communities.
August 3, 2020 (deadline for required Letters of Intent; full applications will be invited by the sponsor)Gilead Medical AffairsCOVID-19 RFP Program: COMMIT (COvid-19 unMet MedIcal needs and associated research exTension)Gilead will consider projects that expand data on clinical course and outcomes in vulnerable populations; study long-term sequelae; or review real-world safety and effectiveness of remdesivir used alone or in combination with other agents.
No deadline indicatedGinkgo BioworksAccess to Platform for Partner COVID-19 ProjectsThe sponsor is offering access to its platform for company and academic labs engaged in developing a diagnostic, drug or vaccine to stop COVID-19.
Applications accepted on a rolling basisGoogle, Inc.COVID-19 Research Credits ProgramGoogle is offering support in the form of Google Cloud research credits to be used for computing services (e.g., storage, computation, data analysis) on Google Cloud Platform for COVID-19 research projects. Note the research credits are meant to fully fund the described project, and credit awards last 90 days.
Ongoing review

William T. Grant Foundation

Spencer Foundation

Rapid Response Research GrantsThe Grant Foundation will use the Rapid Response Research Grants mechanism to fund projects designed to combat youth inequality in the US, a main priority of the Foundation, made worse by the COVID-19 Pandemic. They are joined by the Spencer Foundation in this endeavor. These grants will fund collaborations between researchers and policymakers. Researchers on the team synthesize relevant literature within 6-8 weeks from the start of the grant award, and work with their policy partners to ensure the research results in actions benefiting youth.
Phase 1 Brief Proposals may be submitted anytime; full proposals will be invited by the sponsorRobert Wood Johnson Foundation (RWJF)Pioneering Ideas: Exploring the Future to Build a Culture of HealthRWJF is looking for future-focused projects in four focus areas to benefit their overall Foundation theme - Building a Culture of Health: 1) Future of Evidence, 2) Future of Social Interaction, 3) Future of Food and 4) Future of Work. Emphasis is on health equity. The sponsor notes that while this opportunity is focused on broader trends evolving prior to COVID-19, they are open to projects addressing the pandemic, either directly or indirectly.
August 5, 2020Robert Wood Johnson Foundation (RWJF)Systems for Action Call for Proposals: Supplemental COVID-19 StudiesPrincipal investigators who are currently conducting systems level research as well as those who have recently completed a systems level study are invited to submit a proposal for supplemental COVID-19 funding.  Note RWJF is also planning to offer a second Call for Proposals for new research concerning health systems alignment and COVID-19 in September.
September 4, 2020March of Dimes (MOD)2020 COVID-19 FundMOD will support translational and actionable science leading directly to improved diagnosis, treatment and ultimately prevention for mothers and infants in a pandemic climate. Research priorities for this program are 1) clinical characteristics and 2) maternal immunity and neonatal health.
None indicatedMercatus Center (at George Mason University)COVID-19 Response: A Call for IdeasThe sponsor is seeking proposals for policy briefs, working papers and articles addressing the next COVID-19 challenges facing the US and other countries: Reopening and restarting; institutional challenges, health and science policy; economic and regulatory policy; and monetary policy.
August 31, 2020Merck KgaAResearch Grant for Pandemic PreparednessProject proposals will be considered that leverage modern technologies to create new breakthrough solutions to (1) be more prepared for pandemic outbreaks or (2) work towards existing solutions that could help to fight emerging viral infections as part of the sponsor's overall 2020 Research Grants Program.
Applications accepted on rolling basisMozilla Open Source Support Program (MOSS)COVID-19 Solutions FundMOSS will fund open source technology projects related to COVID-19. Projects should be relatively well along as awardees are expected to use funds within 3 months of receipt.
Applications accepted through March 29, 2021National Aeronautics and Space Administration (NASA)Rapid Response and Novel Research in Earth Science ProposalNASA will provide new or additional support for studies using NASA satellite data to address regional-to-global environmental, economic and/or societal impacts of the COVID-19 pandemic. NASA is encouraging use of artificial intelligence/machine learning techniques.
Continuous submission (contact program officer first)National Cancer Institute (NCI)Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-Supported Projects to be Redirected to COVID-1-Related Research during the CrisisNCI-funded researchers who wish  to be able to contribute their expertise and resources toward a better understanding of the impacts of SARS-CoV-2 infection and COVID-19 disease on cancer patients’ disease progression, response to therapy, care delivery, or survivorship may request variance to use a portion of their NCI project funds to address this crisis.
August 14, 2020National Cancer Institute (NCI)Notice of Special Interest (NOSI): NCI Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-2019) (NOT-CA-20-082)NCI is providing an opportunity for current NCI-funded principal investigators whose postdoctoral fellows have temporarily lost stipend support from a non-profit funder due to COVID-19 to apply for administrative supplements. Supplements would cover the postdoc's salary (plus F&A) for the time and effort the postdoc devotes to the NCI-funded project.
Applications accepted on a rolling basis from May 15, 2020 through January 25, 2022National Center for Advancing Translational Sciences (NCATS)Notice of Special Interest regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel CoronavirusNCATS is interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and then advance the translation of research findings into diagnostics, therapeutics, and vaccines.
Applications accepted on rolling basis from May 15, 2020 to January 25, 2022National Center for Advancing Translational Sciences (NCATS)Notice of Special Interest regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel CoronavirusNCATS is interested in three specific topics: 1) Incorporation of new and emerging data related to SARS-CoV-2 into ongoing research efforts to develop microphysiological systems/tissue chips models for COVID-19; 2) Use of microphysiological systems/tissue chips or evaluating, repurposing or modification of diagnostic tools to enable rapid detection of COVID-19 infection; and 3) Use of microphysiological systems/tissue chips for the rapid development and assessment of potential therapeutic agents for COVID-19

U01 -
October 5, 2020

U34 -
October 16, 2020

National Center for Advancing Translational Sciences (NCAT/NIH)Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)This notice applies to three funding mechanisms offered by NCAT: Cooperative Agreement (U01), Planning Cooperative Agreement (U34) and Exploratory/Developmental Phased Award Cooperative Agreement (UG3/UH3)
Applications accepted on rolling basis and will be handled on an expedited review and award basis; RFA expires January 24, 2021National Center for Advancing Translational Sciences (NCATS)Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) (RFA-TR-20-003)NCATS will fund early-stage clinical trials on existing therapeutic agents that are already marketed or tested in humans in another Phase I clinical trial prior to application submission.
Applications will be accepted on a rolling basis through August 17, 2020.

National Center for Complementary and Integrative Health (NCCIH)

Office of Research on Women's Health (ORWH)

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-AT-20-012)NCCIH is particularly interested in the therapeutic and/or mechanistic effects of natural product-based complementary remedies on SARS-CoV-2 (e.g., herbal therapies, vitamins, supplements, probiotics, microbial therapies, Chinese medicine herbal preparations).

Applications accepted on rolling basis through October 6, 2020

National Center for Complementary and Integrative Health (NCCIH)

Other Participating Institutes:

National Institute on Aging (NIA)

National Institute of Alcohol Abuse and Alcoholism (NIAAA)

Notice of Special Interest: Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)Specific interest involves stress management strategies (including mind and body approaches) that individuals may engage in remotely to address stressors related to social distancing as well as to address recovery and reoccurrence of symptoms during or after COVID-19 infections.
August 21, 2020National Council on Disability (NCD)2021 Progress Report, COVID-19 Broadscale Impacts on People with DisabilitiesNCD is seeking proposals to develop their annual progress report examining COVID-19's impacts on people with disabilities in 7 areas: nondiscriminatory access to healthcare; the direct care workforce; group housing; education; employment; mental health; and communications. Also to be included are discussions concerning the intersection of disability and race, and transportation impacts. The goal of the report is to provide policymakers with insights needed to develop effective policies to improve the welfare of those with disabilities during future national emergencies like COVID-19.

August 10, 2020 for required abstract

September 14, 2020 for invited full proposal

National Geospatial - Intelligence Agency (NGA)Boosting Innovative GEOINT Research Broad Agency Announcement (BIR-R BAA), Topic #1: Modeling the Path to COVID-19 RecoveryNGA will fund retrospective analyses of the early stages of the COVID-19 pandemic that explore the nexus of human behavior, human mobility and spatial heterogeneity in infections disease transmission.
Applications accepted on rolling basis through October 5, 2020National Heart, Lung and Blood Institute (NHLBI)

Notice of Special Interest: Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019

 

Frequently Asked Questions Document (04/10/2020)

Of particular interest to NHLBI are studies that take advantage of human research or unique model systems to study the consequences of SARS-COV-2 infection.
Applications accepted on rolling basis through August 14, 2020National Institute of Allergy and Infectious Diseases (NIAID)

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

Research Project Grants (R01)

Exploratory/Developmental Research Grants (R21)

NIAID is issuing these two program announcements to provide expedited funding mechanisms for research on SARS-CoV2 and COVID-19 to address the public health need for better understanding of virology, immunology, development of animal models and medical countermeasures (see announcements for full list). Another goal is to share findings quickly and broadly. Applications will receive expedited review and award.
Applications accepted on a rolling basis through July 7, 2021National Institute of Allergy and Infectious Diseases (NIAID)Limited Competition Emergency Awards: Shared Personal Protective Resources for COVID-19 Related Vaccine and Treatment Clinical Trials (S10 Clinical Trial Not Allowed) (PAR-20-256)NIAID will provide Personal Protective Equipment (PPE) to directly support the needs of NIAID-funded treatment clinical trials and clinical studies on COVID-19. Eligibility is limited to recipients supported by NIAID's emergency appropriation as outlined in the announcement.
Applications accepted on a rolling basis through July 2, 2021.National Institute of Allergy and Infectious Diseases (NIAID)Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-AI-20-059)NIAID replaced NOT-AI-20-034, a more open-ended NOSI, with one in which they are specifying limited interest areas as follows: 1) Support to BSL3 facilities actively engaged in the SARS-CoV-2/COVID-19 research response; 2) Creation of critical reagents to support the SARS-CoV-2/COVID-19 research response; 3) Expansion of relevant data systems to expeditiously share SARS-CoV-2/COVID-19 research resources with the broad research community; and 4) Expansion of clinical trial infrastructure, or site preparation, for urgent SARS-CoV-2/COVID-19 clinical trial activities.
Deadlines vary by funding mechanism; this Notice expires September 8, 2021.National Institute of Allergy and Infectious Diseases (NIAID)Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)Research areas are: Studies to understand critical aspects of viral infection, replication, pathogenesis and transmission; Studies on the evolution and emergence of SARS-CoV-2 viruses; Development of diagnostic tests; Development of SARS-CoV-2 therapeutic candidates; Identification and evaluation of the innate, cellular and humoral immune responses to SARS-CoV-2 infection; and Development of SARS-CoV-2 vaccine candidates. NIAID will be using the Small Grant (R03), SBIR and STTR funding mechanisms.
Proposals may be submitted anytime until further notice; proposal review is promised within one weekNational Institute of Biomedical Imaging and Bioengineering (NIBIB)Fast-Track Program for COVID-19 Test Development and Distribution - Rapid Acceleration of Diagnostics (RADx)The goal of this program is to enable rapid production of innovative SARS-CoV-2 diagnostic tests. Both early and advanced stage projects will be supported.
Deadlines depend on funding mechanism; this NOSI expires March 31, 2021National Institute of Biomedical Imaging and Bioengineering (NIBIB)Notice of Special Interest: Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)The sponsor will fund applications to develop life-saving technologies for commercialization within one to two years.
Applications accepted on rolling basis through November 10, 2020National Institute of Biomedical Imaging and Bioengineering (NIBIB)Notice of Special Interest: Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)NIBIB is seeking applications from current grantees to develop life-saving technologies that can be ready for commercialization within one to two years.
August 27, 2020National Institute of Corrections/US Department of JusticeCOVID-19 - Operational Challenges for Corrections (20PR07)Through this grant program, NIC is promoting knowledge-sharing around the challenges of addressing COVID-19 within the correctional system.

November 2, 2020

National Institute of Dental and Craniofacial Research (NIDCR)Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCRNIDCR will place high priority on topics of immediate and high impact to protect and ensure safety of personnel and patients in dental practices. These topics include prevention of SARS-COV-2 transmission and improvements in the detection and diagnosis of COVID-19; as well as acquisition of a more robust understanding of SARS-CoV-2 pathogenesis. Topics addressing influence and interaction of sex (a biological variable) and gender (a social construct), race and ethnicity, and those addressing questions about risk, prevention, and health outcomes are also of interest.
December 16, 2020National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) (RFA-DK-20-021)NIDDK will support basic and clinical mechanistic research on susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing disease or adverse acute or chronic outcomes in organs, tissues and biological systems of specific interest to NIDDK (to include diabetes and other metabolic diseases, obesity, endocrine, digestive, liver, pancreas, kidney, urological and hematologic tissues and diseases).
Applications for both types are due August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; February 1, 2021; March 1, 2021; April 1, 2021; and May 3, 2021. This NOSI will expire on May 4, 2021.National Institute of Environmental Health Sciences (NIEHS)Notice of Special Interest: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)NIEHS will support both time-sensitive new projects and emergency competitive revisions from current grantees to study the role of environmental exposures in pathogenicity, transmission, individual susceptability, or prevention and intervention strategies.

August 20, 2020

December 2, 2020

March 2, 2021

National Institute of Mental Health (NIMH)

Other Participating Institutes and Centers:

National Eye Institute

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism

National Institute of Child Health and Human Development

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute on Drug Abuse

National Institute of Nursing Research

National Institute on Minority Health and Health Disparities

National Center for Complementary and Integrative Health

National Center for Advancing Translational Sciences

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) (PAR-20-243)NIMH and partner Institutes and Centers will support research to determine the role and impact of digital-health interventions (e.g., mobile health, telemedicine and telehealth, health information technology, wearable devices) to address secondary health effects of the social, behavioral and economic changes following the COVID-19 pandemic, particularly among populations who experience health disparities and vulnerable populations.
Applications will be accepted on a rolling basis through April 15, 2021.

National Institute of Mental Health (NIMH)

 

Other Participating Institutes:

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism

National Institute on Minority Health and Health Disparities

Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel CoronavirusNIMH is especially interested in research to (1) provide an evidence base for how a disrupted workforce may respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, (2) learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health and (3) address the intersection of COVID-19, mental health, and HIV treatment and prevention.
Not applicableNational Institute of Mental Health (NIMH)Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency Caused by Coronavirus 2019 (COVID-19) (NOT-MH-20-061)With the overall goal of more effective human subjects data harmonization, NIMH is offering guidance on the use of consensus-derived common data elements (CDEs) pertaining to mental health outcomes including a set of newly available measures regarding experiences during the COVID-19 public health emergency and exposures to the SARS-CoV-2 virus.
Applications through December 15, 2020; applications received prior to July 15, 2020 will be considered for Fiscal Year (FY) 2020 funding; those received after that date will be considered for FY 2021 funding

National Institute of Mental Health

Other Participating NIH Components:
National Eye Institute

National Heart, Lung and Blood Institute (withdrawing after 07/31/20)

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism 

National Institute of Child Health and Human Development

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Drug Abuse

National Institute of Nursing Research

National institute on Minority Health and Health Disparities

National Center for Complementary and Integrative Health 

National Center for Advancing Translational Sciences

Notice of Special Interest: Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral and Economic Impact of COVID-19 (NOT-MH-20-053)This NOSI is aimed at current NIH awardees and will use either the Administrative Supplements or Urgent Competitive Revisions mechanisms as outlined in the notice.
Applications accepted through April 14, 2021

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous SystemNINDS will support supplements to address the biology, pathophysiology, prevention, diagnosis, sequelae or treatment of the Novel Coronavirus 2019; NIAAA is interested in studies to better understand, prevent and mitigate some of the neurobiological consequences of SARS-CoV-2 and COVID-19 in individuals with Alcohol Use Disorders.
August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; February 1, 2021National institute on Aging (NIA)NIA Multi-Site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Adult Populations (R01 Clinical Trial Required) (PAR-20-234)NIA will support investigator-initiated multi-site clinical trials of interventions focused on specific aging-related issues to reduce transmission, risk, morbidity, mortality or complications of COVID-19; see program announcement for specific priorities.
Applications accepted on a rolling basis from April 6, 2020 through May 1, 2021

National Institute on Aging (NIA)

Other Participating Institutes:

National Institute of Mental Health (NIMH)

Notice of Special Interest: NIH Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019

 

FAQ Document

This NOSI is designed to address the urgent public health need to better understand the 2019-nCoV, particularly to improve prevention of disease transmission among older adults and mitigation of disease severity/mortality in older adults with COVID-19.
November 7, 2020National Institute on Alcohol Abuse and Alcoholism (NIAAA)Alcohol-HIV/AIDS Program Projects Co-Morbidities, Coinfections and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional) (RFA-AA-20-009)NIAAA is soliciting applications for human studies that will advance operations or implementation research in the context of alcohol and HIV/AIDS by facilitating development of broader systems approaches and interventions. Patterns of alcohol use among people living with HIV (PLWH) affect transmission of HIV, engagement and retention in care and  susceptibility to coinfections including COVID-19.
Applications accepted on rolling basis through April 15, 2021National Institute on Alcohol Abuse and Alcoholism (NIAAA)Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAANIAAA is requesting applications to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes.
October 5, 2020 through September 8, 2022 (dependent on specific program announcement - R01 or R21)National Institute on Deafness and Other Communication Disorders (NIDCD)Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders (NOT-DC-20-008)NIDCD will support research on COVID-19 in relation to the Institute's scientific programs: hearing, balance, taste, smell, voice, speech and language.
October 6, 2020
February 8, 2021
June 8, 2021
October 8, 2021
National Institute on Drug Abuse (NIDA)Notice of Clarification to PAR-19-064, Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) (NOT-DA-20-062)NIDA has released a Notice of Clarification for this program announcement, adding an additional priority area concerning risks and outcomes associated with substance use and COVID-19 infection in the general population and among underserved populations.

Standard NIH deadlines apply; the first deadline will be October 5, 2020

National Institute on Minority Health and Health Disparities (NIMHD)

Other Participating Institutes:

National Institute on Aging (NIA)

National Institute on Drug Abuse (NIDA)

National Cancer Institute (NCI)

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 - Clinical Trial Optional)Will support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters (to include COVID-19) on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.
Applications accepted on a rolling basis through December 15, 2020

National institute on Minority Health and Health Disparities

Other Participating NIH Components:

National Eye Institute

National Institute on Aging

National Institute on Alcoholism and Alcohol Abuse

National Institute of Child Health and Human Development

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Drug Abuse

National Institute of Environmental Health Sciences

National Institute of Mental Health

National Center for Complementary and Integrative Health

National Center for Advancing Translational Sciences

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations (NOT-MD-20-022)Key questions include: To what extent do existing interventions slow the spread of COVID-19 in specific populations and geographic hotspots? To what extent do policies, guidelines, and other interventions facilitate adherence and mitigate the multifaceted impacts of COVID-19 on health in populations that experience health disparities and vulnerable groups? Can established models of crisis and disaster response and management be applied to address the needs of health disparity and other vulnerable populations?
Applications accepted on rolling basis through May 1, 2021

National Institute on Minority Health and Health Disparities (NIMHD)

Other Participating Institutes:

National Institute on Aging (NIA)

National Institute of Mental Health (NIMH)

Notice of Special Interest: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health DisparitiesNIMHD is soliciting research in health disparity populations to better understand: 1) how state and local policies and initiatives mitigate/exacerbate disparities in health services use and health outcomes; 2) the role that community-level protective and resilience factors and interventions have in mitigating the effects of the sector disruptions that the COVID-19 outbreak causes; and 3) how behavioral and/or biological mechanisms may contribute to COVID-19 manifestations.

August 28, 2020

December 1, 2020

National Institutes of Health (NIH)

Participating Institutes:

National Institute on Minority Health and Health Disparities

National Eye Institute

National Institute on Aging

National institute on Alcohol Abuse and Alcoholism

National Institute of Child Health and Human Development

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Drug Abuse

National Institute of Environmental Health Sciences

National Institute of Mental Health

National Institute of Nursing Research

National Center for Complementary and Integrative Health

National Center for Advancing Translational Sciences

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01 - Clinical Trial Optional) (PAR-20-237)Through this program announcement, NIMHD and other NIH institutes and centers will support research with NIH-designated health disparity populations and other vulnerable groups on community interventions to address the adverse psychosocial, behavioral and socioeconomic effects of SARS-CoV-2 and COVID-19; projects should test 1) impacts of mitigation strategies to prevent COVID-19 transmission and 2) already implemented, new or adapted interventions to address adverse consequences of the pandemic on the health of these groups.

September 4, 2020

(Note institutions are limited to 2 applications for this competition; our internal selection process will run through the Office of the Vice Chancellor for Research.)

National Institutes of HealthFY 2021 NIH Director's Early Independence Award (DP5): COVID-19 Proposals (RFA-RM-20-021)This award supports outstanding junior scientists, defined as those currently in non-independent positions at time of application who have not served in a postdoctoral position more than 12  months. Preliminary data are not required. 
September 30, 2020National Institutes of HealthFY 2021 NIH Director's Emergency Transformative Research Award (R01): COVID-19 Proposals (RFA-RM-20-020)The purpose of this award is to provide support for individuals and teams at all career levels who are proposing COVID-19 related projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms. Proposals may address COVID-19 prevention, preparation or response. No preliminary data are required.
N/ANational Institutes of Health (NIH)Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency (NOT-OD-20-118)NIH has issued a reminder relative to a number of COVID-19 Notices of Special Interest that the agency has "resources and guidance that will facilitate data harmonization and the development of robust data sharing plans."

November 12, 2020

March 12, 2021

July 12, 2021

National Institutes of Health (multiple Institutes and Centers)Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down syndrome for the INCLUDE Project (NOT-OD-20-129)The goal of this NOSI is to improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population which may be disproportionately affected by, and/or be at elevated risk for, adverse outcomes from contracting the virus. Multiple institutes and centers are participating and each have specified research objectives as listed in the Notice.

August 7, 2020 for the U24 CDCC

August 7, 2020 OR September 8, 2020 for the three NOSIs

National institutes of Health (NIH) Office of the Director

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-120)

NOSI: Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-121)

NOSI: Emergency Competitive Revisions for Social, Ethical and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-119)

Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) (RFA-OD-20-013)

The NIH Office of the Director, in partnership with the various Institutes, Centers and Offices within NIH, is offering four related program initiatives comprising the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) consortium.

NOT-OD-20-120 will support supplements to individual research awards that include community collaborations or partnerships to support COVID-19 testing for underserved populations.

NOT-OD-20-121 will support supplements to NIH grantees that are part of large-scale networks, consortia, centers and other current programs that have adequate capacity, infrastructure and established community-engaged relationships to support large-scale testing. 

NOT-OD-20-119 will fund research to identify, analyze and address the social, ethical and behavioral factors likely to influence access and uptake of COVID-19 testing in underserved and/or vulnerable populations. Currently funded NIH grantees may apply for work that is related to their funded projects.

RFA-OD-20-013 will fund a single Coordination and Data Collection Center (CDCC) as part of the consortium. Institutions are limited to one application for the CDCC only; our internal selection process runs through the Office of the Vice Chancellor for Research.

No set deadline for proposals in response to Dear Colleague Letter

November 18, 2020 for Ecology and Evolution of Infectious Diseases Program

National Science Foundation (NSF)Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)

NSF encourages investigators to use the Rapid Response Research (RAPID) funding mechanism to address COVID-19 which allows for quick turnaround time to meet project requirements. The first step is to contact the program officer as RAPID proposals require program officer permission to submit.

NSF is also encouraging investigators to submit to existing funding opportunities such as the Ecology and Evolution of Infectious Diseases program (EEID), jointly funded by NSF, NIH, USDA and others; EEID proposals are due November 18, 2020.

Frontier Proposals are due 12/02/20

National Science Foundation/National Institutes of Health (and a host of other federal agencies)Cyber-Physical Systems (CPS)Core research areas of this initiative are control, data analytics and machine learning. NIH mentions supporting "development of CPS research and technology to facilitate medical treatment during a national crisis (e.g., SARS-CoV-2)" (see Section II.D.3 of the program solicitation for details).
No set deadlineNational Science Foundation (NSF)Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-2019)

NSF is inviting RAPID proposals and supplemental funding requests to existing awards to address COVID-19 challenges through data and/or software infrastructure development activities. Again, program officer permission is required prior to proposal submission.

Proposals accepted anytimeNational Science Foundation (NSF)Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels) (NSF 20-105)Noting that COVID-19 is unlikely to be the last pandemic in our lifetime, NSF is encouraging use of synthetic biology, cellular engineering, biosensing and immunoengineering as well as other approaches at the intersection of biology and engineering to address the threat of emerging infectious diseases.
November 18, 2020

National Science Foundation (NSF)

National Institutes of Health (NIH)

National Institute of Food and Agriculture (NIFA)

(International sponsors represent Israel, the United Kingdom and China)

Ecology and Evolution of Infectious Diseases (EEID) (NSF 20-585)This program supports research on the ecological, evolutionary and social drivers that influence transmission dynamics of infectious diseases. Note that the central theme of any proposed project must be the quantitative or computational understanding of pathogen transmission dynamics. Multidisciplinary teams are highly encouraged.
Applications accepted on a rolling basis through March 31, 2021

Office of Behavioral and Social Sciences Research (OBSSR)

 

Other Participating Institutes:

National Heart, Lung and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute

Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social SciencesOBSSR is encouraging urgent competitive supplements and administrative supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts, including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.
Proposals considered on a rolling basisPatient-Centered Outcomes Research Institute (PCORI)COVID-19-Related Enhancements to Existing PCORI-Funded Engagement AwardsOnly PCORI-funded project leads with active Engagement Awards are eligible for this competition. Enhancements may include modest additions to existing aims or an adjunct project that has some relationship to the original award.
Proposals considered on a rolling basisPatient-Centered Outcomes Research Institute (PCORI)COVID-19-Related Enhancements to Existing PCORI-Funded Research ProjectsOnly PCORI-funded principal investigators with active research funding contracts are eligible for this competition. Enhancements may include modest additions to existing aims or an adjunct project that has some relationship to the original award.
August 5, 2020Russell Sage FoundationResearch GrantsFor this deadline, the Foundation will only be accepting letters of inquiry that meet at least one of two criteria: 1) the research is so time-sensitive that the project must start before July 1, 2021; or 2) the research investigates the immediate and long-term social, political, economic and psychological consequences of the COVID-19 pandemic in the US.
Applications accepted on a rolling basis with first review period to begin August 31, 2020Social Science Research Council (SSRC)Just Tech COVID-19 Rapid-Response GrantsSSRC will support innovative research projects across the social sciences and related fields that use remote research methods to detect short- and long-term implications of public health interventions for a range of rights, liberties and public goods. Areas of interest include contact tracing and public health surveillance; voting access/rights; disparities in health data collection and representation; the digital divide; and remote organizing, campaigning and social movements.
August 30, 2020Sorenson Impact FoundationEquitable and Resilient Recovery Grant ProgramThe Foundation is seeking solutions toward a more equitable and resilient recovery from the COVID-19 pandemic and the ensuing economic crisis. Specifically, they are targeting solutions through developing and growing businesses and the communities they are in across three target areas: 1) Equitable access to wealth creation through entrepreneurship, 2) Democratized access to capital and community investment and 3) Workforce development.
August 13, 2020 for initial round; invited finalists will submit additional materials in the FallToronto-Dominion Bank (TD)The 2020 TD Research ChallengeThis North American initiative, open to US and Canadian non-profits, supports organizations developing innovative solutions for a changing world. This year, their focus is on identifying and supporting innovative solutions that address impacts of the COVID-19 pandemic, specifically for communities that are experiencing disproportionate impacts of the virus. TD is looking for holistic approaches that work through their four drivers of change: Financial Security, Vibrant Planet, Connected Communities and Better Health.

August 20, 2020

Note that prior to application preparation, potential applicants are required to consult with the program officer concerning suitability of the proposed project to this program.

US Department of Agriculture (USDA)Rapid Response to Novel Coronavirus (SARS-CoV-2): Innovating Formal and Non-Formal Educational Experiences in Food and Agricultural Sciences During the Time of Social Distancing (see pp. 19-21 of RFA for specifics on this program)USDA is seeking applications addressing the need to develop and deploy rapid, reliable and readily-adoptable strategies in workforce preparation through form K-14 education as well as in youth development through non-formal education - all designed to cultivate interest and competencies in Science, Technology, Engineering and Mathematics (STEM) and agriculture during this challenging time.
August 18, 2020VINNOVAPre-Studies for Innovative Projects in the Health Area that Prevent Future PandemicsVINNOVA is seeking proposals for health-related innovative projects and feasibility studies that will help to curb the spread and effects of COVID-19 and prevent future pandemics. Projects require at least 2 partners: one from business or health care and others from one of the following sectors: academia, health care, the public sector, business and civil society.
October 31, 2020WORK SAFE BC2020 Request for ProposalsThe sponsor wishes to fund research projects to address direct and indirect impacts of COVID-19 which are unique to occupational health and safety, injured or ill worker recovery and safe and sustainable return to work or stay-at-work. Specific topics of interest to WORK SAFE BC are preventing exposure; addressing the needs of vulnerable workers; working from home; medical, rehabilitative and return to work interventions; and post-viral fatigue. Researchers worldwide are invited to apply.